{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T03:57:28Z","timestamp":1771473448509,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ecl.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T03:17:42Z","timestamp":1718680662000},"page":"483-495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lipid Disorders and Pregnancy"],"prefix":"10.1016","volume":"53","author":[{"given":"Daria","family":"Schatoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene Y.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2024.05.009_bib1","series-title":"Williams textbook of endocrinology","first-page":"1581","article-title":"Disorders of Lipid Metabolism","author":"Semenkovich","year":"2020"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.009_bib2","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1053\/j.gastro.2020.11.040","article-title":"New Classification and Management of Abetalipoproteinemia and Related Disorders","volume":"160","author":"Bredefeld","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.009_bib3","first-page":"405","article-title":"Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population","volume":"140","author":"Gagn\u00e9","year":"1989","journal-title":"Can Med Assoc J"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9150(01)00734-1","article-title":"Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies","volume":"162","author":"Belo","year":"2002","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.009_bib5","doi-asserted-by":"crossref","first-page":"610.e1","DOI":"10.1016\/j.ajog.2007.04.024","article-title":"Early pregnancy lipid concentrations and spontaneous preterm birth","volume":"197","author":"Catov","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ecl.2024.05.009_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-319-70178-3_12","article-title":"Role of Estrogens in the Regulation of Liver Lipid Metabolism","volume":"1043","author":"Palmisano","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.009_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1172\/JCI108677","article-title":"Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase","volume":"59","author":"Applebaum","year":"1977","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.009_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bjs\/znab221","article-title":"Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes","volume":"109","author":"Hughes","year":"2021","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pan.2021.12.007","article-title":"Acute pancreatitis in pregnancy and its impact on the maternal and foetal outcomes: A systematic review","volume":"22","author":"Kumar","year":"2022","journal-title":"Pancreatology"},{"issue":"9","key":"10.1016\/j.ecl.2024.05.009_bib11","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ecl.2024.05.009_bib12","article-title":"Therapeutic plasma exchange for the management of severe gestational hypertriglyceridaemic pancreatitis due to lipoprotein lipase mutation","volume":"2020","author":"Kim","year":"2020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.009_bib13","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1097\/MJT.0b013e31825b9e98","article-title":"Management of familial hypertriglyceridemia-induced pancreatitis during pregnancy with therapeutic plasma exchange: a case report and review of literature","volume":"21","author":"Safi","year":"2014","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.009_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jacl.2007.11.001","article-title":"Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in\u00a0vitro fertilization ovulation induction","volume":"2","author":"Lee","year":"2008","journal-title":"J\u00a0Clin Lipidol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.009_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacl.2022.04.002","article-title":"In\u00a0vitro fertilization and hypertriglyceridemic pancreatitis: Case report","volume":"16","author":"Reddy","year":"2022","journal-title":"J\u00a0Clin Lipidol"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.009_bib16","doi-asserted-by":"crossref","first-page":"E862","DOI":"10.1152\/ajpendo.00491.2009","article-title":"Multiple pathways ensure retinoid delivery to milk: studies in genetically modified mice","volume":"298","author":"O'Byrne","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib17","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.4158\/ACCR-2018-0168","article-title":"Severe Hypertriglyceridemia in Pregnancy: A Case Report and Review of the Literature","volume":"5","author":"Kleess","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.ecl.2024.05.009_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an \"FCS score\"","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/ATVBAHA.122.317966","article-title":"Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3)","volume":"43","author":"Ginsberg","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.ecl.2024.05.009_bib20","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/eurheartj\/ehs010","article-title":"Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia","volume":"33","author":"Motazacker","year":"2012","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ecl.2024.05.009_bib21","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1210\/jc.2008-0269","article-title":"A\u00a0New PCSK9 Gene Promoter Variant Affects Gene Expression and Causes Autosomal Dominant Hypercholesterolemia","volume":"93","author":"Blesa","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.009_bib22","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2796.2009.02167.x","article-title":"The unique role of proprotein convertase subtilisin\/kexin 9 in cholesterol homeostasis","volume":"266","author":"Mousavi","year":"2009","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.ATV.0000255311.26383.2f","article-title":"A\u00a0Novel Loss of Function Mutation of PCSK9 Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol","volume":"27","author":"Fasano","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.009_bib25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/ATVBAHA.122.318839","article-title":"New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol","volume":"43","author":"Meng","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2013.09.007","article-title":"APOE p.Leu167del mutation in familial hypercholesterolemia","volume":"231","author":"Awan","year":"2013","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.009_bib27","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1210\/jc.2015-3874","article-title":"The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes","volume":"101","author":"Cenarro","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.009_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.22215","article-title":"Description of a Large Family with Autosomal Dominant Hypercholesterolemia Associated with the APOE p.Leu167del Mutation","volume":"34","author":"Marduel","year":"2013","journal-title":"Hum Mutat"},{"issue":"22","key":"10.1016\/j.ecl.2024.05.009_bib29","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ecl.2024.05.009_bib30","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1161\/CIRCULATIONAHA.119.044795","article-title":"Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease","volume":"141","author":"Hu","year":"2020","journal-title":"Circulation"},{"issue":"45","key":"10.1016\/j.ecl.2024.05.009_bib31","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.ecl.2024.05.009_bib32","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide Prevalence of Familial Hypercholesterolemia","volume":"75","author":"Beheshti","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2024.05.009_bib33","series-title":"Prevalence and incidence of rare diseases: bibliographic data. Orphanet Report Series Rare diseases collection","year":"2023"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib34","article-title":"Homozygous Familial Hypercholesterolemia in Canada","volume":"2","author":"Brown","year":"2023","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2010.11.005","article-title":"Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan","volume":"214","author":"Mabuchi","year":"2011","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.ecl.2024.05.009_bib36","article-title":"Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"26","key":"10.1016\/j.ecl.2024.05.009_bib37","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/0024-3205(95)00230-4","article-title":"Alterations of serum lipid levels and their biological relevances during and after pregnancy","volume":"56","author":"An-Na","year":"1995","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.ecl.2024.05.009_bib38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/jcem-64-4-704","article-title":"Correlation of Hormones with Lipid and Lipoprotein Levels During Normal Pregnancy and Postpartum","volume":"64","author":"Desoye","year":"1987","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.009_bib39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/0002-9378(88)90193-7","article-title":"Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy","volume":"158","author":"Herrera","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"15","key":"10.1016\/j.ecl.2024.05.009_bib40","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIRCULATIONAHA.110.990929","article-title":"Pregnancy Outcomes in Familial Hypercholesterolemia","volume":"124","author":"Toleikyte","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.009_bib41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/humrep\/dex052","article-title":"Preconception maternal lipoprotein levels in relation to fecundability","volume":"32","author":"Pugh","year":"2017","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.009_bib42","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1210\/jc.2013-3936","article-title":"Lipid Concentrations and Couple Fecundity: The LIFE Study","volume":"99","author":"Schisterman","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"19","key":"10.1016\/j.ecl.2024.05.009_bib43","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","article-title":"Apolipoprotein(a) Isoforms and the Risk of Vascular Disease","volume":"55","author":"Erqou","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ecl.2024.05.009_bib44","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.ecl.2024.05.009_bib45","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) Levels in Familial Hypercholesterolemia","volume":"63","author":"Alonso","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.009_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/joim.12981","article-title":"Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities","volume":"287","author":"Vuorio","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ecl.2024.05.009_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2018.11.040","article-title":"Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia","volume":"281","author":"Vuorio","year":"2019","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.009_bib48","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1194\/jlr.R060582","article-title":"Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?","volume":"57","author":"Boffa","year":"2016","journal-title":"JLR (J Lipid Res)"},{"issue":"12","key":"10.1016\/j.ecl.2024.05.009_bib49","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1194\/jlr.P094763","article-title":"Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex\u00a0vivo fibrinolysis","volume":"60","author":"Boffa","year":"2019","journal-title":"JLR (J Lipid Res)"},{"issue":"7","key":"10.1016\/j.ecl.2024.05.009_bib50","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/ATVBAHA.112.248765","article-title":"Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis","volume":"32","author":"Kamstrup","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"10.1016\/j.ecl.2024.05.009_bib51","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ecl.2024.05.009_bib52","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for Preventing the Recurrence of Venous Thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.009_bib54","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.fertnstert.2016.01.014","article-title":"Searching for a common mechanism for placenta-mediated pregnancy complications and cardiovascular disease: role of lipoprotein(a)","volume":"105","author":"Romagnuolo","year":"2016","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) Reduction in Persons with Cardiovascular Disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.ecl.2024.05.009_bib56","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJMoa2211023","article-title":"Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease","volume":"387","author":"O'Donoghue","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ecl.2024.05.009_bib57","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ecl.2024.05.009_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv370","article-title":"ODYSSEY FH I and FH II: 78\u00a0week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia","author":"Kastelein","year":"2015","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ecl.2024.05.009_bib59","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for Homozygous Familial Hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib60","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.transci.2015.11.008","article-title":"Severe dyslipidemia in pregnancy: The role of therapeutic apheresis","volume":"53","author":"Russi","year":"2015","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib61","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/tera.1420280316","article-title":"Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase","volume":"28","author":"Minsker","year":"1983","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.ecl.2024.05.009_bib62","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/erc.11.196","article-title":"Statin use during pregnancy: a systematic review and meta-analysis","volume":"10","author":"Kusters","year":"2012","journal-title":"Expet Rev Cardiovasc Ther"},{"issue":"6","key":"10.1016\/j.ecl.2024.05.009_bib63","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1701-2163(15)30565-X","article-title":"The Fetal Safety of Statins: A Systematic Review and Meta-Analysis","volume":"36","author":"Zarek","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.009_bib64","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: A systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"Journal of Clinical Lipidology"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association","volume":"39","author":"Newman","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ecl.2024.05.009_bib66","unstructured":"Hale TW, Krutsch K. Hale\u2019s Medications & Mothers\u2019 Milk 2023: A Manual of Lactational Pharmacology: Twentieth Edition2022."},{"issue":"4","key":"10.1016\/j.ecl.2024.05.009_bib67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1753495X15594082","article-title":"Severe gestational hypertriglyceridemia: A practical approach for clinicians","volume":"8","author":"Wong","year":"2015","journal-title":"Obstet Med"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.009_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4158\/EP.5.1.33","article-title":"Severe Hypertriglyceridemia and Acute Pancreatitis During Pregnancy: Treatment with Gemfibrozil","volume":"5","author":"Saadi","year":"1999","journal-title":"Endocr Pract"},{"issue":"6 Suppl","key":"10.1016\/j.ecl.2024.05.009_bib69","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.09.002","article-title":"National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2","volume":"9","author":"Jacobson","year":"2015","journal-title":"Journal of clinical lipidology"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.009_bib70","doi-asserted-by":"crossref","first-page":"F45","DOI":"10.1136\/adc.2006.099085","article-title":"Cognitive assessment of children at age 2\u00bd years after maternal fish oil supplementation in pregnancy: a randomised controlled trial","volume":"93","author":"Dunstan","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"10.1016\/j.ecl.2024.05.009_bib71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.reprotox.2005.07.014","article-title":"Colesevelam hydrochloride does not cause maternal or fetal toxicity in rats and rabbits","volume":"21","author":"Marquis","year":"2006","journal-title":"Reprod Toxicol"},{"issue":"5","key":"10.1016\/j.ecl.2024.05.009_bib72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/1751-486X.12068","article-title":"New Pharmacologic Treatments for Familial Hypercholesterolemia","volume":"17","author":"McDonough","year":"2013","journal-title":"Nursing for Women's Health"},{"issue":"1","key":"10.1016\/j.ecl.2024.05.009_bib73","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/jog.15813","article-title":"PCSK9 inhibitor use during pregnancy in a case of familial hypercholesterolemia complicated with coronary artery disease","volume":"50","author":"Suzuki","year":"2024","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ecl.2024.05.009_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/985646","article-title":"IgG Placental Transfer in Healthy and Pathological Pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"17","key":"10.1016\/j.ecl.2024.05.009_bib75","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa1611930","article-title":"Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N\u00a0Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852924000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T05:27:25Z","timestamp":1722317245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852924000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0889852924000392"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.009","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid Disorders and Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}